Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 4, 2008, Pages 314-321

  Tauseef, Mohammad ^a,b   Shahid, Mohd ^a   Sharma, Krishna K ^b   Fahim, Mohammad ^a  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR; CHOLESTEROL; FREE RADICAL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPRENALINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; ASPIRIN; CHOLESTEROL; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GLUTATHIONE; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA-2; VASOCONSTRICTOR AGENTS; VASODILATION;

RATTUS; RATTUS NORVEGICUS;

EID: 52049092285     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00277.x     Document Type: Article

References (45)

1. Mombouli JV, Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol 1999 31 : 61 4.
2. Libby P, Masanori A, Kinlay S, Selwyn A, Ganz P. Lipid lowering improves endothelial functions. Int J Cardiol 2000 74 : S3 S10.
3. Gokkusu C, Mostafazadeh T. Changes of oxidative stress in various tissues by long-term administration of vitamin E in hypercholesterolemic rats. Clin Chim Acta 2003 328 : 155 61.
4. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis. Am Heart J 1993 125 : 958 71.
5. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986 314 : 488 500.
6. Dusting GJ, Fennessy P, Yin ZL, Gurevich V. Nitric oxide in atherosclerosis: vascular protection or villain? Clin Exp Pharmacol Physiol 1998 25 : S34 S41.
7. Merkel LA, Rivera LM, Bilder GE, Perrone MH. Differential alteration of vascular reactivity in rabbit aorta with modest elevation of serum cholesterol. Circ Res 1990 67 : 550 5.
8. Wu R, Lamontagne D, de Champlain J. Anti-oxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 2002 105 : 387 92.
9. Kodama M, Yamasaki Y, Sakamoto K, Yoshioka R, Matsuhisa M, Kajimoto Y et al. Antiplatelet drugs attenuate progression of carotid intima-mediated thicknesss in subjects with type 2 diabetse. Thromb Res 2000 97 : 239 45.
10. Cyrus T, Sung S, Zhao L, Funk CD, Tang S, Pratico D. Effect of low dose aspirin on vascular inflammation, plaque stability and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 2002 106 : 1282 7.
11. Hussain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 1998 97 : 716 20.
12. Aruoma OI, Halliwel B. The iron binding and iron hydroxyl scavenging action of anti-inflammatory drugs. Xenobiotics 1988 18 : 459 70.
13. Wollard AC, Wolff SP, Bascal ZA. Antioxidant characteristics of some potential anticataract agents: studies of aspirin, paracetamol and bendazac provide support for an oxidative component of cataract. Free Radic Boil Med 1990 9 : 299 305.
14. Podhaisky HP, Abate A, Polte T, Oberle S, Schröder H. Aspirin protects endothelial cells from oxidative stress: possible synergism with vitamin E. FEBS Lett 1997 417 : 349 51.
15. El-Midaoui A, Wu R, de Champlin J. Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. J Hypertens 2002 20 : 1407 12.
16. Tauseef M, Sharma KK, Fahim M. Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action. Eur J Pharmacol 2007 556 : 136 43.
17. Grosser N, Schröder H. Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler Thromb Vasc Biol 2003 23 : 1345 51.
18. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974 11 : 151 69.
19. Wright JR, Colby HD, Miles PR. Cytosolic factors that affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys 1981 206 : 296 304.
20. Lefer DJ, Granger DN. Monocyte rolling in early atherogenesis; vital role in lesion development. Circ Res 1999 84 : 1353 5.
21. Hajjar DP, Nicholson AC. Atherosclerosis: an understanding of the cellular and molecular basis of the disease promises new approaches for its treatment in the near future. Am Scient 1995 83 : 460 7.
22. Saini HK, Arneja AS, Dhalla NS. Role of cholesterol in cardiovascular dysfunction. Can J Cardiol 2004 20 : 333 46.
23. Monobe H, Yamanari H, Nakamura K, Ohe T. Effects of low dose aspirin on endothelial function in hypertensive patients. Clin Cardiol 2001 24 : 207 9.
24. Ranke C, Hecker H, Creutzig A, Alexander K. Dose dependent effect of aspirin on carotid atherosclerosis. Circulation 1993 87 : 1873 9.
25. Sobal G, Menzel JE, Sinzinger H. Influence of acetylsalicylic acid on oxidation of native and glycated low-density lipoprotein. Life Sci 2000 66 : 1987 98.
26. Costanzo A, Moretti F, Burgio VL, Bravi C, Guido F, Levrero M et al. Endothelial activation by angiotensin II through NF-kappaB and p38 pathways: Involvement of NF-kappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 2003 195 : 402 10.
27. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997 336 : 973 9.
28. Ashraf ZA, Hussain ME, Fahim M. Antiatherosclerotic effects of dietary supplementation of garlic and turmeric: restoration of endothelial function in rats. Life Sci 2005 77 : 837 57.
29. Chen M, Masaki T, Sawamura T. Lox-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002 95 : 89 100.
30. Kouraklis G, Patapis P, Misiakos E, Glinavou A, Sioka C, Karayiannakos PE. Effect of acetylsalicylic acid on experimental atherogenesis induced in rabbits. Int Angiol 2004 23 : 139 43.
31. Prasad K, Lee P. Suppression of oxidative stress as a mechanism of reduction of hypercholestreolemic atheroscelrosis by aspirin. J Cardiovasc Pharmacol Ther 2003 8 : 61 9.
32. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M et al. Reversal of obesity- and diet-induced insulin resistance by salicylate or targeted disruption of IKKbeta. Science 2001 293 : 1673 7.
33. Akaike M, Azuma H, Kagawa A, Matsumoto K, Hayashi I, Tamura K et al. Effect of aspirin treatment on serum concentration of lipoprotein(a) in patients with atherosclerotic diseases. Clin Chem 2002 48 : 1452 9.
34. Fields M, Lewis CG, Bureau I. Aspirin reduces blood cholesterol in copper deficient rats: a potential antioxidant agent. Metabolism 2001 50 : 558 61.
35. Srisawat S, Phivthong-ngam L, Unchern S, Chantharaksri U, Govitrapong P, Sanvarinda Y. Improvement of vascular function by chronic administration of a cyclo-oxygenase inhibitor in cholesterol-fed rabbits. Clin Exp Pharmacol Physiol 2000 30 : 405 12.
36. Mugge A, Brandes RP, Boger RH, Dwenger A, Bode-Boger S, Kienke S et al. Vascular release of superoxide radicals is enhanced in hypercholsterolemic rabbits. J Cardiovasc Pharmacol 1994 24 : 994 8.
37. Forstermann U, Mugge A, Alheid U, Haverich A, Frolich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988 62 : 185 90.
38. Noon JP, Walker BR, Hand MF, Webb DJ. Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. Cardiovasc Res 1998 38 : 480 4.
39. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO III, Panza JA. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension 1997 30 : 918 21.
40. Rubanyi G, Vanhoutte PM. Endothelium removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine. J Cardiovasc Pharmacol 1985 7 : 139 44.
41. Lu Z, Qu P, Xu K, Han C. Β-adrenoceptors in endothelium of rabbit coronary artery and alteration in atherosclerosis. Biol Signals 1995 4 : 150 9.
42. Miyata N, Yamaura H, Tsuchida K, Otomo S, Kamata K, Kasuya Y. Changes in responsiveness of the aorta to vasorelaxant agents in genetically diabetic rats: a study in WBN/Kob rats. Life Sci 1992 50 : 1363 9.
43. Smith CC, Prichard BN, Betteridge DJ. Plasma and platelet free catecholamine concentrations in patients with familial hypercholesterolaemia. Clin Sci 1992 82 : 113 6.
44. Tagaya A, Tamaoki J, Kazuyki N, Nagai A. Role of the sarcoplasmic sodium pump in nitroprusside induced vasodilation of pulmonary artery. Res Commun Mol Pathol Pharmacol 1997 97 : 291 300.
45. Hu ZW, Miler JW, Hoffman BB. Induction of enhanced release EDRF after prolonged exposure to α-adrenergic agionist. J Cardiovasc Pharmacol 1994 23 : 337 43.